We observed that the expression of NLRP3 in CD14+ PBMCs in basal conditions was significantly higher in COPD patients (Figure 3A, black bars) than non-smokers (Figure 3A, white bars) and smokers (Figure 3A, dotted bars). This evidence concerns the gene NLRP3 and chronic obstructive pulmonary disease.